Mak LY, Gane E, Schwabe C, Yoon KT, et al. A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis. J Hepatol 2022 Dec 10:S0168-8278(22)03320-7. doi: 10.1016/j.jhep.2022.
PMID: 36513186